AH
Assort HealthAssort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.
2 Pulse stories
CT
Celea TherapeuticsClinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopathic pulmonary fibrosis, spun out of PureTech Health.
4 Pulse stories
Total Raised
$222M
$180M
Assort HealthCelea Therapeutics
Last Valuation
$1.2B
Assort HealthCelea Therapeutics
Biotech
Sector
Biotech
2023
Founded
2025
San Francisco, California
HQ
Boston, MA
Private
Status
Private
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Celea Therapeutics investors
RA Capital ManagementLeaps by BayerPureTech Health
Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Celea Therapeutics.